tirzepatide alzheimer clinical trial Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs Tirzepatide Demonstrates Sustained Weight Loss

It builds on previously published research which found the drug had "consistent benefits" on preventing heart attacks, strokes, and death due to cardiovascular causes in those with type 2 diabetes and chronic kidney disease

After 3 days in the presence of unlabelled GSH ( t = 72 h), cells were extracted for metabolomic analysis as described above

Mediterranean Chicken and Quinoa Salad Ingredients Grilled chicken breast 1 cup quinoa Cucumber Cherry tomatoes Kalamata olives Feta cheese Olive oil Red wine vinegar Parsley Instructions: Combine ingredients and lightly toss

Since GLP-1 medications are known to reduce gut motility, scientists have wondered whether they could play a role in causing SIBO or IMO

Further studies should now be performed to identify the precise mechanisms involved with the action of DPP-4i

10.1016/j.jad.2024.11.077 J